2018
DOI: 10.1038/s41393-018-0190-z
|View full text |Cite|
|
Sign up to set email alerts
|

Clinical efficacy of upper limb robotic therapy in people with tetraplegia: a pilot randomized controlled trial

Abstract: There were small improvements in motor strength and SCIM-III scores in the RT group, but there were no statistically significant differences between the groups. Further studies are required for a better understanding of the effects of RT for people with tetraplegia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
51
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(51 citation statements)
references
References 39 publications
0
51
0
Order By: Relevance
“…Cortes et al [14] found the InMotion wrist robot to be feasible, safe, and associated with significant results for motor performance in 10 persons with chronic SCI. Kim et al [15] found some improvements in strength and independence, but not significant, in a group of SCI inpatients. Other studies, all case studies, have found similar systems (e.g., the Mahi Exo II, the Rice Wrist and the ReoGo) to be feasible, safe, and exhibit some functional improvements [16][17][18].…”
Section: Introductionmentioning
confidence: 94%
“…Cortes et al [14] found the InMotion wrist robot to be feasible, safe, and associated with significant results for motor performance in 10 persons with chronic SCI. Kim et al [15] found some improvements in strength and independence, but not significant, in a group of SCI inpatients. Other studies, all case studies, have found similar systems (e.g., the Mahi Exo II, the Rice Wrist and the ReoGo) to be feasible, safe, and exhibit some functional improvements [16][17][18].…”
Section: Introductionmentioning
confidence: 94%
“…Subsequently, 39 articles were excluded because they did not respect eligibility criteria. As a result, 11 papers were included in the qualitative synthesis (PRISMA flow diagram was depicted by Figure 1): 5 case series, [25][26][27][28][29] 1 parallel-group controlled trial, [30] 2 RCT, [31,34] 2 systematic reviews [32,33] and one longitudinal intervention study. [35] The studies included in this systematic review were published from 201225 to 202034, covering several Nations from all over the world; more in detail, seven studies were from the Americas (two from Canada [25,32] and five from USA [26,27,29,30,33]), two from Europe (1 from Netherlands [28] and one from UK [35]), and two from Asia (Republic of Korea [31,34]).…”
Section: Evidence Synthesismentioning
confidence: 99%
“…Evidence level and study quality of the included studies Due to the high clinical heterogeneity of the included studies; thus, the results are described qualitatively. Based on the Oxford Centre for Evidence-Based (OCEBM) 2011 Levels of Evidence, [34] we included two systematic reviews [32,33] (Level 1), 2 RCT [31,34] (Level 2), one parallel-group controlled trial [30] (Level 3), one longitudinal intervention trial [35] (Level 3), and five case series (Level 4). [25][26][27][28][29] The study cohort sample sizes were highly heterogeneous in the research studies, ranging from 5 (case series) [28] to 34 (RCT) [31] for clinical trials; nevertheless, the systematic reviews included larger samples (73 study participants by Singh et al [32] and 88 by Yozbatiran et al [33]).…”
Section: Evidence Synthesismentioning
confidence: 99%
See 2 more Smart Citations